The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cytomegalovirus Assay Market Research Report 2025
Synopsis
The global Cytomegalovirus Assay market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Cytomegalovirus Assay is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Cytomegalovirus Assay is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Cytomegalovirus Assay in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Cytomegalovirus Assay include Abbott, Danaher, BD, bioMerieux, Bio-Rad, Eiken Chemical, ELITech Group, Enzo Biochem and Fujirebio (Miraca Holdings Inc.), etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cytomegalovirus Assay, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cytomegalovirus Assay.
Report Scope
The Cytomegalovirus Assay market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cytomegalovirus Assay market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cytomegalovirus Assay companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Danaher
BD
bioMerieux
Bio-Rad
Eiken Chemical
ELITech Group
Enzo Biochem
Fujirebio (Miraca Holdings Inc.)
Merck
Qiagen
Abcam
BioVision (Boai NKY Medical Holdings Ltd.)
DiaSorin Molecular
Norgen Biotek
Segment by Type
Enzyme-Linked Immunosorbent Assays (ELISA)
PCR Assays
DNA Assays
Others
Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cytomegalovirus Assay companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Cytomegalovirus Assay market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Cytomegalovirus Assay is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Cytomegalovirus Assay is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Cytomegalovirus Assay in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Cytomegalovirus Assay include Abbott, Danaher, BD, bioMerieux, Bio-Rad, Eiken Chemical, ELITech Group, Enzo Biochem and Fujirebio (Miraca Holdings Inc.), etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cytomegalovirus Assay, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cytomegalovirus Assay.
Report Scope
The Cytomegalovirus Assay market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cytomegalovirus Assay market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cytomegalovirus Assay companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Danaher
BD
bioMerieux
Bio-Rad
Eiken Chemical
ELITech Group
Enzo Biochem
Fujirebio (Miraca Holdings Inc.)
Merck
Qiagen
Abcam
BioVision (Boai NKY Medical Holdings Ltd.)
DiaSorin Molecular
Norgen Biotek
Segment by Type
Enzyme-Linked Immunosorbent Assays (ELISA)
PCR Assays
DNA Assays
Others
Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cytomegalovirus Assay companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cytomegalovirus Assay Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Enzyme-Linked Immunosorbent Assays (ELISA)
1.2.3 PCR Assays
1.2.4 DNA Assays
1.2.5 Others
1.3 Market by Application
1.3.1 Global Cytomegalovirus Assay Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cytomegalovirus Assay Market Perspective (2019-2030)
2.2 Cytomegalovirus Assay Growth Trends by Region
2.2.1 Global Cytomegalovirus Assay Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cytomegalovirus Assay Historic Market Size by Region (2019-2024)
2.2.3 Cytomegalovirus Assay Forecasted Market Size by Region (2025-2030)
2.3 Cytomegalovirus Assay Market Dynamics
2.3.1 Cytomegalovirus Assay Industry Trends
2.3.2 Cytomegalovirus Assay Market Drivers
2.3.3 Cytomegalovirus Assay Market Challenges
2.3.4 Cytomegalovirus Assay Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cytomegalovirus Assay Players by Revenue
3.1.1 Global Top Cytomegalovirus Assay Players by Revenue (2019-2024)
3.1.2 Global Cytomegalovirus Assay Revenue Market Share by Players (2019-2024)
3.2 Global Cytomegalovirus Assay Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cytomegalovirus Assay Revenue
3.4 Global Cytomegalovirus Assay Market Concentration Ratio
3.4.1 Global Cytomegalovirus Assay Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cytomegalovirus Assay Revenue in 2023
3.5 Cytomegalovirus Assay Key Players Head office and Area Served
3.6 Key Players Cytomegalovirus Assay Product Solution and Service
3.7 Date of Enter into Cytomegalovirus Assay Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cytomegalovirus Assay Breakdown Data by Type
4.1 Global Cytomegalovirus Assay Historic Market Size by Type (2019-2024)
4.2 Global Cytomegalovirus Assay Forecasted Market Size by Type (2025-2030)
5 Cytomegalovirus Assay Breakdown Data by Application
5.1 Global Cytomegalovirus Assay Historic Market Size by Application (2019-2024)
5.2 Global Cytomegalovirus Assay Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cytomegalovirus Assay Market Size (2019-2030)
6.2 North America Cytomegalovirus Assay Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cytomegalovirus Assay Market Size by Country (2019-2024)
6.4 North America Cytomegalovirus Assay Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cytomegalovirus Assay Market Size (2019-2030)
7.2 Europe Cytomegalovirus Assay Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cytomegalovirus Assay Market Size by Country (2019-2024)
7.4 Europe Cytomegalovirus Assay Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cytomegalovirus Assay Market Size (2019-2030)
8.2 Asia-Pacific Cytomegalovirus Assay Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cytomegalovirus Assay Market Size by Region (2019-2024)
8.4 Asia-Pacific Cytomegalovirus Assay Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cytomegalovirus Assay Market Size (2019-2030)
9.2 Latin America Cytomegalovirus Assay Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cytomegalovirus Assay Market Size by Country (2019-2024)
9.4 Latin America Cytomegalovirus Assay Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cytomegalovirus Assay Market Size (2019-2030)
10.2 Middle East & Africa Cytomegalovirus Assay Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cytomegalovirus Assay Market Size by Country (2019-2024)
10.4 Middle East & Africa Cytomegalovirus Assay Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Cytomegalovirus Assay Introduction
11.1.4 Abbott Revenue in Cytomegalovirus Assay Business (2019-2024)
11.1.5 Abbott Recent Development
11.2 Danaher
11.2.1 Danaher Company Detail
11.2.2 Danaher Business Overview
11.2.3 Danaher Cytomegalovirus Assay Introduction
11.2.4 Danaher Revenue in Cytomegalovirus Assay Business (2019-2024)
11.2.5 Danaher Recent Development
11.3 BD
11.3.1 BD Company Detail
11.3.2 BD Business Overview
11.3.3 BD Cytomegalovirus Assay Introduction
11.3.4 BD Revenue in Cytomegalovirus Assay Business (2019-2024)
11.3.5 BD Recent Development
11.4 bioMerieux
11.4.1 bioMerieux Company Detail
11.4.2 bioMerieux Business Overview
11.4.3 bioMerieux Cytomegalovirus Assay Introduction
11.4.4 bioMerieux Revenue in Cytomegalovirus Assay Business (2019-2024)
11.4.5 bioMerieux Recent Development
11.5 Bio-Rad
11.5.1 Bio-Rad Company Detail
11.5.2 Bio-Rad Business Overview
11.5.3 Bio-Rad Cytomegalovirus Assay Introduction
11.5.4 Bio-Rad Revenue in Cytomegalovirus Assay Business (2019-2024)
11.5.5 Bio-Rad Recent Development
11.6 Eiken Chemical
11.6.1 Eiken Chemical Company Detail
11.6.2 Eiken Chemical Business Overview
11.6.3 Eiken Chemical Cytomegalovirus Assay Introduction
11.6.4 Eiken Chemical Revenue in Cytomegalovirus Assay Business (2019-2024)
11.6.5 Eiken Chemical Recent Development
11.7 ELITech Group
11.7.1 ELITech Group Company Detail
11.7.2 ELITech Group Business Overview
11.7.3 ELITech Group Cytomegalovirus Assay Introduction
11.7.4 ELITech Group Revenue in Cytomegalovirus Assay Business (2019-2024)
11.7.5 ELITech Group Recent Development
11.8 Enzo Biochem
11.8.1 Enzo Biochem Company Detail
11.8.2 Enzo Biochem Business Overview
11.8.3 Enzo Biochem Cytomegalovirus Assay Introduction
11.8.4 Enzo Biochem Revenue in Cytomegalovirus Assay Business (2019-2024)
11.8.5 Enzo Biochem Recent Development
11.9 Fujirebio (Miraca Holdings Inc.)
11.9.1 Fujirebio (Miraca Holdings Inc.) Company Detail
11.9.2 Fujirebio (Miraca Holdings Inc.) Business Overview
11.9.3 Fujirebio (Miraca Holdings Inc.) Cytomegalovirus Assay Introduction
11.9.4 Fujirebio (Miraca Holdings Inc.) Revenue in Cytomegalovirus Assay Business (2019-2024)
11.9.5 Fujirebio (Miraca Holdings Inc.) Recent Development
11.10 Merck
11.10.1 Merck Company Detail
11.10.2 Merck Business Overview
11.10.3 Merck Cytomegalovirus Assay Introduction
11.10.4 Merck Revenue in Cytomegalovirus Assay Business (2019-2024)
11.10.5 Merck Recent Development
11.11 Qiagen
11.11.1 Qiagen Company Detail
11.11.2 Qiagen Business Overview
11.11.3 Qiagen Cytomegalovirus Assay Introduction
11.11.4 Qiagen Revenue in Cytomegalovirus Assay Business (2019-2024)
11.11.5 Qiagen Recent Development
11.12 Abcam
11.12.1 Abcam Company Detail
11.12.2 Abcam Business Overview
11.12.3 Abcam Cytomegalovirus Assay Introduction
11.12.4 Abcam Revenue in Cytomegalovirus Assay Business (2019-2024)
11.12.5 Abcam Recent Development
11.13 BioVision (Boai NKY Medical Holdings Ltd.)
11.13.1 BioVision (Boai NKY Medical Holdings Ltd.) Company Detail
11.13.2 BioVision (Boai NKY Medical Holdings Ltd.) Business Overview
11.13.3 BioVision (Boai NKY Medical Holdings Ltd.) Cytomegalovirus Assay Introduction
11.13.4 BioVision (Boai NKY Medical Holdings Ltd.) Revenue in Cytomegalovirus Assay Business (2019-2024)
11.13.5 BioVision (Boai NKY Medical Holdings Ltd.) Recent Development
11.14 DiaSorin Molecular
11.14.1 DiaSorin Molecular Company Detail
11.14.2 DiaSorin Molecular Business Overview
11.14.3 DiaSorin Molecular Cytomegalovirus Assay Introduction
11.14.4 DiaSorin Molecular Revenue in Cytomegalovirus Assay Business (2019-2024)
11.14.5 DiaSorin Molecular Recent Development
11.15 Norgen Biotek
11.15.1 Norgen Biotek Company Detail
11.15.2 Norgen Biotek Business Overview
11.15.3 Norgen Biotek Cytomegalovirus Assay Introduction
11.15.4 Norgen Biotek Revenue in Cytomegalovirus Assay Business (2019-2024)
11.15.5 Norgen Biotek Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Cytomegalovirus Assay Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Enzyme-Linked Immunosorbent Assays (ELISA)
Table 3. Key Players of PCR Assays
Table 4. Key Players of DNA Assays
Table 5. Key Players of Others
Table 6. Global Cytomegalovirus Assay Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Cytomegalovirus Assay Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Cytomegalovirus Assay Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Cytomegalovirus Assay Market Share by Region (2019-2024)
Table 10. Global Cytomegalovirus Assay Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Cytomegalovirus Assay Market Share by Region (2025-2030)
Table 12. Cytomegalovirus Assay Market Trends
Table 13. Cytomegalovirus Assay Market Drivers
Table 14. Cytomegalovirus Assay Market Challenges
Table 15. Cytomegalovirus Assay Market Restraints
Table 16. Global Cytomegalovirus Assay Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Cytomegalovirus Assay Market Share by Players (2019-2024)
Table 18. Global Top Cytomegalovirus Assay Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cytomegalovirus Assay as of 2023)
Table 19. Ranking of Global Top Cytomegalovirus Assay Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Cytomegalovirus Assay Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Cytomegalovirus Assay Product Solution and Service
Table 23. Date of Enter into Cytomegalovirus Assay Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Cytomegalovirus Assay Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Cytomegalovirus Assay Revenue Market Share by Type (2019-2024)
Table 27. Global Cytomegalovirus Assay Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Cytomegalovirus Assay Revenue Market Share by Type (2025-2030)
Table 29. Global Cytomegalovirus Assay Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Cytomegalovirus Assay Revenue Market Share by Application (2019-2024)
Table 31. Global Cytomegalovirus Assay Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Cytomegalovirus Assay Revenue Market Share by Application (2025-2030)
Table 33. North America Cytomegalovirus Assay Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Cytomegalovirus Assay Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Cytomegalovirus Assay Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Cytomegalovirus Assay Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Cytomegalovirus Assay Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Cytomegalovirus Assay Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Cytomegalovirus Assay Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Cytomegalovirus Assay Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Cytomegalovirus Assay Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Cytomegalovirus Assay Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Cytomegalovirus Assay Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Cytomegalovirus Assay Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Cytomegalovirus Assay Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Cytomegalovirus Assay Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Cytomegalovirus Assay Market Size by Country (2025-2030) & (US$ Million)
Table 48. Abbott Company Detail
Table 49. Abbott Business Overview
Table 50. Abbott Cytomegalovirus Assay Product
Table 51. Abbott Revenue in Cytomegalovirus Assay Business (2019-2024) & (US$ Million)
Table 52. Abbott Recent Development
Table 53. Danaher Company Detail
Table 54. Danaher Business Overview
Table 55. Danaher Cytomegalovirus Assay Product
Table 56. Danaher Revenue in Cytomegalovirus Assay Business (2019-2024) & (US$ Million)
Table 57. Danaher Recent Development
Table 58. BD Company Detail
Table 59. BD Business Overview
Table 60. BD Cytomegalovirus Assay Product
Table 61. BD Revenue in Cytomegalovirus Assay Business (2019-2024) & (US$ Million)
Table 62. BD Recent Development
Table 63. bioMerieux Company Detail
Table 64. bioMerieux Business Overview
Table 65. bioMerieux Cytomegalovirus Assay Product
Table 66. bioMerieux Revenue in Cytomegalovirus Assay Business (2019-2024) & (US$ Million)
Table 67. bioMerieux Recent Development
Table 68. Bio-Rad Company Detail
Table 69. Bio-Rad Business Overview
Table 70. Bio-Rad Cytomegalovirus Assay Product
Table 71. Bio-Rad Revenue in Cytomegalovirus Assay Business (2019-2024) & (US$ Million)
Table 72. Bio-Rad Recent Development
Table 73. Eiken Chemical Company Detail
Table 74. Eiken Chemical Business Overview
Table 75. Eiken Chemical Cytomegalovirus Assay Product
Table 76. Eiken Chemical Revenue in Cytomegalovirus Assay Business (2019-2024) & (US$ Million)
Table 77. Eiken Chemical Recent Development
Table 78. ELITech Group Company Detail
Table 79. ELITech Group Business Overview
Table 80. ELITech Group Cytomegalovirus Assay Product
Table 81. ELITech Group Revenue in Cytomegalovirus Assay Business (2019-2024) & (US$ Million)
Table 82. ELITech Group Recent Development
Table 83. Enzo Biochem Company Detail
Table 84. Enzo Biochem Business Overview
Table 85. Enzo Biochem Cytomegalovirus Assay Product
Table 86. Enzo Biochem Revenue in Cytomegalovirus Assay Business (2019-2024) & (US$ Million)
Table 87. Enzo Biochem Recent Development
Table 88. Fujirebio (Miraca Holdings Inc.) Company Detail
Table 89. Fujirebio (Miraca Holdings Inc.) Business Overview
Table 90. Fujirebio (Miraca Holdings Inc.) Cytomegalovirus Assay Product
Table 91. Fujirebio (Miraca Holdings Inc.) Revenue in Cytomegalovirus Assay Business (2019-2024) & (US$ Million)
Table 92. Fujirebio (Miraca Holdings Inc.) Recent Development
Table 93. Merck Company Detail
Table 94. Merck Business Overview
Table 95. Merck Cytomegalovirus Assay Product
Table 96. Merck Revenue in Cytomegalovirus Assay Business (2019-2024) & (US$ Million)
Table 97. Merck Recent Development
Table 98. Qiagen Company Detail
Table 99. Qiagen Business Overview
Table 100. Qiagen Cytomegalovirus Assay Product
Table 101. Qiagen Revenue in Cytomegalovirus Assay Business (2019-2024) & (US$ Million)
Table 102. Qiagen Recent Development
Table 103. Abcam Company Detail
Table 104. Abcam Business Overview
Table 105. Abcam Cytomegalovirus Assay Product
Table 106. Abcam Revenue in Cytomegalovirus Assay Business (2019-2024) & (US$ Million)
Table 107. Abcam Recent Development
Table 108. BioVision (Boai NKY Medical Holdings Ltd.) Company Detail
Table 109. BioVision (Boai NKY Medical Holdings Ltd.) Business Overview
Table 110. BioVision (Boai NKY Medical Holdings Ltd.) Cytomegalovirus Assay Product
Table 111. BioVision (Boai NKY Medical Holdings Ltd.) Revenue in Cytomegalovirus Assay Business (2019-2024) & (US$ Million)
Table 112. BioVision (Boai NKY Medical Holdings Ltd.) Recent Development
Table 113. DiaSorin Molecular Company Detail
Table 114. DiaSorin Molecular Business Overview
Table 115. DiaSorin Molecular Cytomegalovirus Assay Product
Table 116. DiaSorin Molecular Revenue in Cytomegalovirus Assay Business (2019-2024) & (US$ Million)
Table 117. DiaSorin Molecular Recent Development
Table 118. Norgen Biotek Company Detail
Table 119. Norgen Biotek Business Overview
Table 120. Norgen Biotek Cytomegalovirus Assay Product
Table 121. Norgen Biotek Revenue in Cytomegalovirus Assay Business (2019-2024) & (US$ Million)
Table 122. Norgen Biotek Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cytomegalovirus Assay Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Cytomegalovirus Assay Market Share by Type: 2023 VS 2030
Figure 3. Enzyme-Linked Immunosorbent Assays (ELISA) Features
Figure 4. PCR Assays Features
Figure 5. DNA Assays Features
Figure 6. Others Features
Figure 7. Global Cytomegalovirus Assay Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Cytomegalovirus Assay Market Share by Application: 2023 VS 2030
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Ambulatory Surgical Centers Case Studies
Figure 12. Others Case Studies
Figure 13. Cytomegalovirus Assay Report Years Considered
Figure 14. Global Cytomegalovirus Assay Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Cytomegalovirus Assay Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Cytomegalovirus Assay Market Share by Region: 2023 VS 2030
Figure 17. Global Cytomegalovirus Assay Market Share by Players in 2023
Figure 18. Global Top Cytomegalovirus Assay Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cytomegalovirus Assay as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Cytomegalovirus Assay Revenue in 2023
Figure 20. North America Cytomegalovirus Assay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Cytomegalovirus Assay Market Share by Country (2019-2030)
Figure 22. United States Cytomegalovirus Assay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Cytomegalovirus Assay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Cytomegalovirus Assay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Cytomegalovirus Assay Market Share by Country (2019-2030)
Figure 26. Germany Cytomegalovirus Assay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Cytomegalovirus Assay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Cytomegalovirus Assay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Cytomegalovirus Assay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Cytomegalovirus Assay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Cytomegalovirus Assay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Cytomegalovirus Assay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Cytomegalovirus Assay Market Share by Region (2019-2030)
Figure 34. China Cytomegalovirus Assay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Cytomegalovirus Assay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Cytomegalovirus Assay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Cytomegalovirus Assay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Cytomegalovirus Assay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Cytomegalovirus Assay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Cytomegalovirus Assay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Cytomegalovirus Assay Market Share by Country (2019-2030)
Figure 42. Mexico Cytomegalovirus Assay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Cytomegalovirus Assay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Cytomegalovirus Assay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Cytomegalovirus Assay Market Share by Country (2019-2030)
Figure 46. Turkey Cytomegalovirus Assay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Cytomegalovirus Assay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Abbott Revenue Growth Rate in Cytomegalovirus Assay Business (2019-2024)
Figure 49. Danaher Revenue Growth Rate in Cytomegalovirus Assay Business (2019-2024)
Figure 50. BD Revenue Growth Rate in Cytomegalovirus Assay Business (2019-2024)
Figure 51. bioMerieux Revenue Growth Rate in Cytomegalovirus Assay Business (2019-2024)
Figure 52. Bio-Rad Revenue Growth Rate in Cytomegalovirus Assay Business (2019-2024)
Figure 53. Eiken Chemical Revenue Growth Rate in Cytomegalovirus Assay Business (2019-2024)
Figure 54. ELITech Group Revenue Growth Rate in Cytomegalovirus Assay Business (2019-2024)
Figure 55. Enzo Biochem Revenue Growth Rate in Cytomegalovirus Assay Business (2019-2024)
Figure 56. Fujirebio (Miraca Holdings Inc.) Revenue Growth Rate in Cytomegalovirus Assay Business (2019-2024)
Figure 57. Merck Revenue Growth Rate in Cytomegalovirus Assay Business (2019-2024)
Figure 58. Qiagen Revenue Growth Rate in Cytomegalovirus Assay Business (2019-2024)
Figure 59. Abcam Revenue Growth Rate in Cytomegalovirus Assay Business (2019-2024)
Figure 60. BioVision (Boai NKY Medical Holdings Ltd.) Revenue Growth Rate in Cytomegalovirus Assay Business (2019-2024)
Figure 61. DiaSorin Molecular Revenue Growth Rate in Cytomegalovirus Assay Business (2019-2024)
Figure 62. Norgen Biotek Revenue Growth Rate in Cytomegalovirus Assay Business (2019-2024)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
